Table 3.
Adverse events.
| References | Experimental | Control | ||
|---|---|---|---|---|
| Adverse events | n | Adverse events | n | |
| Bai et al.2023 (49) | ·Moxibustion allergy | 2/30 | ·Irregular vaginal bleeding | 2/30 |
| ·Residual feeling after moxibustion | 1/30 | |||
| ·Needle sensation remains after acupuncture | 1/30 | |||
| Dong 2021 (50) | – | – | ·Slight palpitation | 2/18 |
| Du et al.2022 (51) | ·Subcutaneous congestion | 2/40 | ·Anorexia | 5/40 |
| ·Vomiting | 2/40 | |||
| Liu 2021 (52) | ·Subcutaneous congestion | 1/22 | ·Nausea | 1/22 |
| ·Slight increases in liver function AL and AST were detected after 12 weeks of treatment | 1/22 | |||
| Shi 2022 (53) | ·Subcutaneous congestion | 2/30 | ·Nausea | 1/30 |
| Zhao 2024 (96) | ·Slight scald | 2/30 | – | – |
n (number of events/total).